Nippon Kayaku Kabushiki Kaisha

Akira Fujita

Takashi Terada

Tochiro Tatee

Takashi Takahira

Makoto Hosono

Giichi Izumi

Yasuhiko Furuta

Michiko Sakai

Junpei Itoh

Osamu Ishizuka

The present invention relates to novel pharmaceutical use of forskolin derivatives represented by the general formula: ##STR1## wherein R.sup.1, R.sup.2 and Ac are as defined later ##STR2## (wherein R.sup.3 and R.sup.4 are each hydrogen or lower alkyl group, or R.sup.3 and R.sup.4 may be combined to represent lower alkylene group which may have oxygen or nitrogen atom in the linking chain, and n is an integer of 1 to 5); R.sup.2 represents hydrocarbon group having 2 to 3 carbon atoms; and Ac represents acetyl group. The above-mentioned forskolin derivative or a physiologically acceptable salt thereof can be used as a platelet aggregation inhibiting or controlling agent, spasmolytic agent, therapeutic agent for skin ulcer, peripheral circulation improving agent for limbs and differentiation inducing and promoting agent.

Pharmaceutical use of forskolin derivatives

Growing community of inventors

Omiya, Japan

Akira Fujita